Most events were mild to moderate and occurred during dose escalation
Following the remodelling phase, a higher proportion of synthesised type I collagen, a corresponding decrease in cellularity, glycosaminoglycan content and type III collagen (Sharma and Maffulli 2005) can be observed
CADD: predicting the deleteriousness of variants throughout the human genome
However, it should always be used under the supervision of a healthcare practitioner as an incorrect dosage can lead to adverse side effects such as nausea, dizziness, headache, and fatigue
Recent Findings Many children and adolescents will likely benefit from GLP1-RA treatment for Binge Eating Disorder, Night Eating Syndrome, and Other Specified Eating or Feeding Disorder